Potassium humate inhibits carrageenan-induced paw oedema and a graft-versus-host reaction in rats

Inflammopharmacology

Volumn 18, Issue 1, 2010, Pages 33-39

  Naude P J W ^a   Cromarty, A D ^a   Van Rensburg, Constance E Jansen ^a  

^a UNIVERSITY OF PRETORIA   (South Africa)

Author keywords

Anti inflammatory; Carrageenan induced inflammation; Graft versus host reaction; Potassium humate; Rats

Indexed keywords

ANTIINFLAMMATORY AGENT; CARRAGEENAN; CYCLOPHOSPHAMIDE; DEXAMETHASONE; HUMATE POTASSIUM; INDOMETACIN; LIGNITE; UNCLASSIFIED DRUG; ZYMATE;

ALLOGRAFT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; DRUG EFFICACY; FEMALE; GRAFT VERSUS HOST REACTION; HUMIC SUBSTANCE; IMMUNE DEFICIENCY; INFLAMMATION; MASS SPECTROMETRY; NONHUMAN; PAW EDEMA; PRIORITY JOURNAL; RAT; SHEEP ERYTHROCYTE; THIN LAYER CHROMATOGRAPHY;

ANIMALS; CARRAGEENAN; COAL; EDEMA; FEMALE; GRAFT VS HOST REACTION; HUMIC SUBSTANCES; POTASSIUM COMPOUNDS; RATS; RATS, SPRAGUE-DAWLEY; SHEEP;

EID: 75949090078     PISSN: 09254692     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10787-009-0026-8     Document Type: Article

References (28)

1. JH Antin JL Ferrara 1992 Cytokine dysregulation and acute graft-versus-host disease Blood 80 2964 2968 1:STN:280:DyaK3s7gsVCqsw%3D%3D 1467511
2. Baatz H (1988) Moortherapie en der frauenheilkunde. In: Flaig W, Goecke C, Kauffels W (eds) Moortherapie: Grundlagen und anwendungen. Ueberreuter, Berlin, pp 161-168
3. R Baigorri M Fuentes G Gonzlez-Gaitano, et al. 2009 Complementary multianalytical approach to study the distinctive structural features of the main humic fractions in solution: gray humic acid, brown humic acid, and fulvic Acid J Agric Food Chem 2009 57 3266 3272 10.1021/jf8035353
4. S Bani A Kaul B Khan, et al. 2005 Immunosuppressive properties of an ethyl acetate fraction from Euphorbia royleana J Ethnopharmacol 99 185 192 10.1016/j.jep.2004.12.017 15894125 (Pubitemid 40724392)
5. JJ Bergh IJ Cronje J Dekker, et al. 1997 Non-catalytic oxidation of water-slurried coal with oxygen: identification of fulvic acids and acute toxicity Fuel 76 149 154 10.1016/S0016-2361(96)00194-9 1:CAS:528: DyaK2sXhtFWrtL8%3D
6. ME Botes J Dekker CEJ van Rensburg 2002 Phase I trial with oral oxihumate in HIV-infected patients Drug Dev Res 57 34 39 10.1002/ddr.10117 1:CAS:528:DC%2BD38XptVelsrk%3D (Pubitemid 35375531)
7. RJ Gau HL Yang SN Chow, et al. 2000 Humic acid suppresses the LPS-induced expression of cell-surface adhesion proteins through the inhibition of NF-κB activation Toxicol Appl Pharm 166 59 67 10.1006/taap.2000.8954 1:CAS:528:DC%2BD3cXktlSnuro%3D (Pubitemid 30470620)
8. S Golbs V Fuchs M Kühnert, et al. 1982 Pränataltoxikologische Testung von Huminsäuren an Laboratoriumsratten Arch Exp Vet Med 36 179 185 1:CAS:528:DyaL38Xlt1Snt7Y%3D
9. BW Gutting F Bouzahzah LK Kong, et al. 2003 Oxazolone and diclofenac-induced PLN assay reactions are attenuated in mice orally pretreated with the respective compound: potential role of the induction of regulatory mechanisms following enteric administration Toxicol Appl Pharm 189 120 133 10.1016/S0041-008X(03)00091-7 1:CAS:528:DC%2BD3sXktVOgurY%3D (Pubitemid 36638280)
10. R Hartenstein 1981 Sludge decomposition and stabilization Science 212 743 749 10.1126/science.212.4496.743 1:CAS:528:DyaL3MXkvVGmtL8%3D 17752228
11. JD Huber VS Hau L Borg CR Campos RD Egleton TP Davis 2002 Blood-brain barrier tight junctions are altered during a 72-h exposure to λ-carrageenan-induced inflammatory pain Am J Physiol Heart Circ Physiol 283 1531 1537
12. GK Jooné CEJ van Rensburg 2004 An in vitro investigation of the anti-inflammatory properties of potassium humate Inflammation 28 169 174 10.1023/B:IFLA.0000039563.90066.5d 15527172 (Pubitemid 39186620)
13. Kleinschmidt J (1988) Moortherapie bei rheumatischen erkrankungen. Flaig W, Goecke C, Kauffels W (eds) Moortherapie: Grundlagen und anwendungen. Ueberreuter, Berlin, Germany, pp 216-224
14. Kovarik R (1988) Über die anwendung von präparaten aus torf, bzw. Huminstoffen bei gynäkologischen erkrankungen. Flaig W, Goecke C, Kauffels W (eds) Moortherapie: Grundlagen und anwendungen. Ueberreuter, Berlin, pp 177-197
15. Lent W (1988) Bericht über die moorforschung und anwendung in der DDR, Polen, Tschechoslowakei Und UdSSR. In: Flaig W, Goecke C, Kauffels W (eds) Moortherapie: Grundlagen und anwendungen. Ueberreuter, Berlin, pp 169-176
16. A Manosroi A Saraphanchotiwitthaya J Manosroi 2005 In vivo immunomodulating activity of wood extracts from Clausena excavata Burm J Ethnopharmacol 102 5 9 10.1016/j.jep.2005.04.033 1:STN:280: DC%2BD28%2FovVKkuw%3D%3D 16023813 (Pubitemid 41375931)
17. F Nantel D Denis R Gordon, et al. 1999 Distribution and regulation of cyclooxygenase-2 in carrageenan-induced inflammation Br J Pharmacol 128 853 859 10.1038/sj.bjp.0702866 1:CAS:528:DyaK1MXntFCiurY%3D 10556918 (Pubitemid 29494701)
18. MD Paciolla S Kolla SA Jansen 2002 The reduction of dissolved iron species by humic acid and subsequent production of reactive oxygen species Adv Environ Res 7 169 178 10.1016/S1093-0191(01)00129-0 1:CAS:528: DC%2BD38Xns1Cgsrg%3D (Pubitemid 35154331)
19. A Pascher J Klupp J Langrehr, et al. 2005 Anti-TNF-alpha therapy for acute rejection in intestinal transplantation Transplant Proc 3 635 1636
20. M Petersson U Wiberg T Lundeberg, et al. 2001 Oxytocin decreases carrageenan-induced inflammation in rats Peptides 22 479 1484 10.1016/S0196-9781(01)00469-7 (Pubitemid 32770021)
21. MC Recio RM Giner L Uriburu, et al. 2000 In vivo activity of pseudoguaianolide sesquiterpene lactones in acute and chronic inflammation Life Sci 66 2509 2518 10.1016/S0024-3205(00)00585-3 1:CAS:528:DC%2BD3cXjsFelsbc%3D 10883729
22. K Satoshi S Tsurufuji 1985 Analysis of the factor(s) involved in the pathogenesis of zymosan-induced inflammation in rats Japanese J Pharmacol 38 177 184 10.1254/jjp.38.177
23. I Schepetkin A Khlebnikov BS Kwon 2002 Medical drugs from humus matter: focus on mumie Drug Develop Res 57 40 159 10.1002/ddr.10116 (Pubitemid 35375532)
24. KK Sharma PK Mediratta KH Reeta, et al. 2004 Acute and delayed restraint stress-induced changes in nitric oxide producing neurons in limbic regions Neuroscience 125 981 993 10.1016/j.neuroscience.2003.12.046 (Pubitemid 38553905)
25. A Skowron-Cendrzak M Bubak J Dembowska 1978 Local graft versus host reaction in the xenogeneic system Arch Immunol Ther Exp 26 1087 1090 1:STN:280:DyaE1M7msVymtw%3D%3D
26. HF Smit BH Kroes A Van den Berg, et al. 2000 Immunomodulatory and anti-inflammatory activity of Picrorhiza scrophulariiflora J Ethnopharmacol 73 101 109 10.1016/S0378-8741(00)00268-3 1:STN:280:DC%2BD3M%2FnsVygtw%3D%3D 11025145 (Pubitemid 30750490)
27. CEJ Van Rensburg P Naude 2009 Potassium humate inhibits complement activation and the production of inflammatory cytokines in vitro Inflammation 32 270 276 10.1007/s10753-009-9130-6 19507015
28. CEJ Van Rensburg JR Snyman T Mokoele, et al. 2007 Brown coal derived humate inhibits contact hypersensitivity: an efficacy, toxicity and teratogenicity study in rats Inflammation 30 148 152 10.1007/s10753-007-9031-5 1:CAS:528:DC%2BD2sXhtFGgsrzK 17620003 (Pubitemid 47573143)